Stories and useful information.
Publication template with author, medical reviewer, date of update and sources. The remaining publications are being transferred from the current site.
A Parent’s Story: Our 16-Year-Old Son With Autism
A Parent’s Story: Our 16-Year-Old Son With Autism Age: 16 years Country: United Kingdom Diagnosis: Autism Spectrum Disorder (ASD) Regenerative cell therapy at Stem Plus Clinic: February 2026 Treatment duration: 4 days…
ReadPatient stories · 29.08.2026A Father’s Story: My 5-Year-Old Son With Autism
We live in Ireland, and our son is now 5 years old. Before the therapy, our biggest concerns were his speech, limited eye contact, and difficulties interacting with other people.
ReadPatient stories · 29.08.2026A Mother’s Story: Our 8-Year-Old Son From Ireland
When we first came to StemPlus, our son was 8 years old. One of our biggest concerns was his extreme sensory sensitivity.
ReadPatient stories · 29.08.2026A Mother’s Story: Our 6-Year-Old Son With Autism
Our son is 6 years old and has autism spectrum disorder. One of our biggest challenges was his behavior.
ReadPatient stories · 29.08.2026A Mother’s Story: My 10-Year-Old Son With Autism
A Mother’s Story: My 10-Year-Old Son With Autism Age: 10 years Diagnosis: Autism Spectrum Disorder (ASD) Regenerative cell therapy: November 2025 My son is 10 years old and has autism spectrum disorder.
ReadPublications · 28.08.2026Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for Parkinson’s Disease: A Randomized Trial
The primary research team was from the McGovern Medical School at UTHealth Houston (University of Texas Health Science Center at Houston), USA.
ReadPublications · 28.08.2026Therapeutic Efficacy of Mesenchymal Stem Cells (MSCs) in Alzheimer’s Disease: A Review of Clinical Results
This is a review of clinical studies, not a single trial. The authors selected and analyzed 17 clinical studies on MSCs in Alzheimer’s disease.
ReadPublications · 28.08.2026Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases
This is not a single clinical trial, but a peer-reviewed scientific review article. The authors analyzed preclinical and early clinical studies on the use of mesenchymal stromal cells (MSCs) in neurodegenerative…
ReadPublications · 28.08.2026Mesenchymal Stem Cells in the Treatment of Human Diseases: Molecular Mechanisms and Clinical Studies
The study was conducted by a large Chinese research team. Authors: Xia Han, Rongdong Liao, Xiang Li, Cantong Zhang, Shaochuan Huo, Lei Qin, Yi Xiong, Tailin He, Guozhi Xiao, and Tianfeng Zhang.
ReadPublications · 28.08.2026Exosomes in Aging and Age-Related Disorders: Mechanisms, Therapeutic Potential, and Challenges
The authors are Sahar Safaei, Sepideh Sohrabi, Pouya Zahmatkesh, Mohammad Sadegh Soltani-Zangbar, and Leili Aghebati Maleki.
ReadPublications · 28.08.2026Therapy With Mesenchymal Stem Cells in Parkinson’s Disease: History and Perspectives
The authors represented several scientific organizations in Brazil, including departments at the Federal University of Triângulo Mineiro (UFTM), the Nanocell Institute, the São José do Rio Preto Medical School, the…
ReadPublications · 28.08.2026Multilineage-Differentiating Stress-Enduring Cells (Muse Cells): An Easily Accessible, Pluripotent Stem Cell Niche with Unique and Powerful Properties for Multiple Regenerative Medicine Applications
The work was conducted by researchers at the Department of Neuroscience, Biomedicine, and Movement Sciences, University of Verona, Italy. Corresponding author: Riccardo Ossanna.
ReadArchiveMore publications
The remaining stories and articles are on the blog of the current site until they are transferred.
Go to the current blog